Just like a doctor adjusts the dose of a medication to the patient's needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to ...
As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...
Contemporary AD systemic selection remains largely preference- and logistics-driven, despite modest EASI-75/EASI-90 response rates with Th2 biologics and JAK inhibitors at 12–16 weeks. The GEP-497 ...
Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic ...
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced a ...
Recent estimates of chronic pain prevalence in the United States indicate that more than 50 million adults (20.5 percent) report experiencing pain on most days or every day (Yong, Mullins, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results